Charles Schwab Investment Management Inc Jazz Pharmaceuticals PLC Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 615,717 shares of JAZZ stock, worth $66.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
615,717
Previous 615,517
0.03%
Holding current value
$66.5 Million
Previous $75.8 Million
0.85%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding JAZZ
# of Institutions
600Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$664 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$650 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$267 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$252 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$213 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.77B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...